Abbott Labs' surprise guidance bump is a major positive for its shareholders

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Source link

About The Author

Scroll to Top